For years, long COVID has carried the shadow of a brain on fire — inflammation assumed to be the hidden engine of its most debilitating symptoms. A Finnish neuroimaging study now gently displaces that assumption, finding no meaningful difference in brain inflammation between long COVID patients and healthy people, while pointing instead toward the brain's emotional centers as a more likely source of suffering. The discovery does not diminish the reality of what millions endure, but it redraws the map — suggesting that healing may require tending not only to the body's defenses, but to the deep
Brain inflammation unlikely driver of long COVID, study suggests emotional dysregulation instead
Inflammation may be strongest right after infection, then diminish over time
So if there's no inflammation in the brain, what's actually causing long COVID symptoms?
That's the question the study doesn't fully answer. What it does say is that emotional dysregulation—heightened activity in the brain's emotion centers—correlates with the worst symptoms. But correlation isn't causation. The inflammation might have triggered the dysregulation early on, then faded.
Right. And we should be careful here. This is 14 patients. That's a small sample. The study shows no widespread inflammation in this group, but that doesn't mean inflammation plays no role in long COVID broadly. Some patients might have inflammation; others might not.
Fair point. The researchers also found that patients scanned early after infection showed more inflammation than those further out. So maybe the inflammation story is real, just time-limited.
If inflammation fades but symptoms persist, what's keeping people sick?
The study suggests emotional dysregulation in the hippocampus and amygdala might be part of it. But again, that's one piece. Long COVID is clearly complex.
And we don't know if that heightened activity is a cause or a consequence of being sick and anxious for a long time. If I'm exhausted and my life is disrupted, my amygdala is going to light up too.
Exactly. The study points toward emotional regulation therapies as potentially helpful, but it's not saying that's the whole answer.
So what should patients actually do with this information?
Carefully. Don't throw out anti-inflammatory approaches based on one study. But do consider that stress management and emotional support might be part of what helps.
And keep watching. This is one piece of a much larger puzzle about what long COVID actually is.
Le Pouls
- Millions of people remain caught in long COVID's grip — fatigue, cognitive fog, anxiety, and depression persisting months or years after infection — with no clear biological explanation to guide treatment.
- The leading hypothesis, that smoldering brain inflammation was to blame, has been quietly undermined: PET and MRI scans of long COVID patients showed inflammatory activity no higher than that of healthy controls, and far lower than MS patients.
- A more unexpected signal emerged — those suffering the most severe depression and anxiety showed heightened activity in the hippocampus and amygdala, the brain's centers for memory, emotion, and stress response.
- A temporal clue complicates the picture further: patients scanned closer to their initial infection showed more white matter inflammation, suggesting any inflammatory phase may peak early and then recede.
- The research is now redirecting clinical thinking away from anti-inflammatory treatments and toward therapies targeting emotional dysregulation — a shift that could reshape care for long COVID patients worldwide.
For years, long COVID has carried the shadow of a brain on fire — inflammation assumed to be the hidden engine of its most debilitating symptoms. A Finnish neuroimaging study now gently displaces that assumption, finding no meaningful difference in brain inflammation between long COVID patients and healthy people, while pointing instead toward the brain's emotional centers as a more likely source of suffering. The discovery does not diminish the reality of what millions endure, but it redraws the map — suggesting that healing may require tending not only to the body's defenses, but to the deeper architecture of how the mind processes stress and feeling.
For months, the working assumption among researchers was that long COVID's most stubborn symptoms — the unrelenting fatigue, the mental fog, the anxiety and depression — were being driven by inflammation quietly burning inside the brain. A study from the University of Turku in Finland has challenged that picture in meaningful ways.
Using PET scans sensitive to neuroinflammation and MRI scans capable of revealing structural damage, researchers examined 14 long COVID patients alongside healthy controls and patients with multiple sclerosis. The results were striking in their absence: long COVID patients showed significantly less inflammatory activity in white matter than MS patients, and no measurable difference from healthy individuals in markers of brain inflammation or neurodegeneration.
What the study did find, however, was something less expected. Among long COVID patients, those reporting the most severe depression, anxiety, and diminished quality of life showed elevated cellular activity in the hippocampus and amygdala — regions governing memory, emotional regulation, and the body's stress response. This raised the possibility that emotional dysregulation, not inflammation, may be the primary driver of the worst symptoms in at least some patients.
There is also a timing dimension worth holding. Patients scanned within 16 months of infection showed more white matter inflammation than those further removed from it, suggesting any inflammatory response may flare early and then subside. Lead researcher Laura Airas noted that long COVID appears to be a condition that evolves, with different mechanisms potentially dominant at different stages.
For the millions living with long COVID, the implications are significant. If inflammation is not the persistent culprit, anti-inflammatory treatments may offer little relief. The research instead points toward psychological and emotional therapies — interventions designed to address the specific brain regions that appear to be amplifying suffering long after the initial infection has passed.
For months, researchers have suspected that long COVID's stubborn symptoms—the fatigue that won't lift, the fog that clouds thinking, the anxiety and depression that settle in—might stem from inflammation smoldering inside the brain. A new study from the University of Turku in Finland challenges that assumption. Using advanced brain imaging on 14 long COVID patients, researchers found no widespread inflammation in the brain tissue when compared to healthy people. The findings, published in the Journal of Neurology, suggest the story of long COVID's persistence may be more complicated than a simple inflammatory process.
The research team deployed two imaging techniques to look for trouble. PET scans, which are sensitive to neuroinflammation, and MRI scans, which reveal structural changes and white matter damage, were performed on all participants. Blood work was drawn to check for markers of neuronal and glial injury. The comparison group included not just healthy controls but also patients with multiple sclerosis, a disease known to produce clear brain inflammation. When the results came back, the long COVID patients showed significantly lower inflammatory activity in white matter than the MS patients did. Between long COVID patients and healthy controls, there was essentially no difference in markers of brain inflammation or neurodegeneration.
Yet the study did surface something unexpected. Among the long COVID patients, those who reported the most severe depression and anxiety, along with the poorest quality of life, showed heightened cellular activity in two specific brain regions: the hippocampus and the amygdala. These are the areas that handle memory, emotional regulation, and how the body responds to stress. The connection was clear enough that the researchers began to wonder whether emotional dysregulation—rather than inflammation—might be driving the worst symptoms in at least some patients.
There is a temporal wrinkle worth noting. Patients scanned within 16 months of their initial infection showed more white matter inflammatory activity than those further out from infection. This pattern suggests that whatever inflammation does occur in long COVID may flare early and then fade. Laura Airas, the neuroimmunologist who led the study, put it plainly: inflammation may be most prominent right after infection and diminish as time passes. The implication is that long COVID is not a static condition but one that evolves, with different biological mechanisms potentially dominating at different stages.
The findings reframe how clinicians might think about treatment. If brain inflammation is not the primary culprit in persistent symptoms, then flooding the system with anti-inflammatory drugs may not be the answer. Instead, the research points toward interventions that target stress and emotional regulation—therapies that address the dysregulation happening in the brain's emotion centers. For the millions of people worldwide living with long COVID, some experiencing symptoms for years after infection, this distinction could matter enormously. It means the path forward may involve not just biological repair but also psychological and emotional support, tailored to address the specific regions of the brain that appear to be driving the worst of their suffering.
Citations marquantes
We did not observe evidence of widespread brain inflammation in patients with long COVID when compared to healthy controls— Professor Laura Airas, University of Turku
Patients with prolonged symptoms may benefit more from treatments targeting stress and emotional regulation rather than therapies aimed solely at reducing inflammation— University of Turku research team